Myriad Genetics, Inc. · NASDAQ:MYGN
BlackRock, Inc. reported a 8.50% stake in Myriad Genetics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed Apr 7, 2026
BlackRock, Inc. reported a 8.50% stake in Myriad Genetics, Inc., 7,976,163 shares, as a passive investor on Mar 31, 2026. Filed Apr 7, 2026 (Schedule 13G/A).
- Stake
- 8.50%
- Shares
- 7,976,163
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 8.50% | 7,976,163 |
Source
Related
- Myriad Genetics, Inc.
- BlackRock, Inc.
- Myriad Genetics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 17, 2025
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026
- Form 4 · Fox Jennifer Lynne · Sep 8, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Sep 4, 2026
- Form 4 · Wheeler Benjamin Richard · Aug 17, 2026